Biography

Jeffrey Guss, M.D., is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was co-principal investigator and director of therapist training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer-related existential distress. He is currently a study therapist for a trial of psilocybin-assisted therapy for alcoholism and for the MAPS MDMA-AT for PTSD study. To assist even more researchers and patients, he also co-wrote the therapy manual for Yale’s depression and psilocybin study. Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture, and Society. He is an instructor and mentor for the Center for Psychedelic Therapies & Research certificate program and maintains a full-time private practice.